Pharmacological subgroup
A10A – INSULINE UND ANALOGA
9Decisions
19Patient groups
Added benefit by patient group
- Not proven19
Subgroups
Decisions, newest first
- 2025-02-20AwiqliInsulin icodecNot proven
- 2025-02-20AwiqliInsulin icodecNot proven: 4 of 4 patient groups
- 2020-10-15SuliquaInsulin glargin/LixisenatidNot proven: 2 of 2 patient groups
- 2019-05-16TresibaInsulin degludecNot proven: 2 of 2 patient groups
- 2018-08-16SuliquaInsulin glargin/LixisenatidNot proven: 2 of 2 patient groups
- 2016-02-04XultophyInsulin degludec/LiraglutidNot proven
- 2015-10-15XultophyInsulin degludec/LiraglutidNot proven: 3 of 3 patient groups
- 2015-08-20TresibaInsulin degludecNot proven: 3 of 3 patient groups
- 2014-10-16TresibaInsulin degludecNot proven
Data status: 2026-10-29